Product Information
ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by Major Pharmaceuticals, priced at $0.5592 per EA under NDC 00904705699. Its NADAC has been published 218 times since Jun 22, 2022.
FDA first approved this application on Jan 18, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 200 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904705699
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRIN; DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207944FDA Approved
1/18/2017
TE Code
AB
On Market Since
1/30/2017
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 218 times since Jun 22, 2022, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5592 per EA |
|---|---|
| All-time high | $0.8911 (Jul 13, 2022) |
| All-time low | $0.5561 (Mar 18, 2026) |
| 52-week high | $0.6072 |
| 52-week low | $0.5561 |
| Median price | $0.6646 |
| Average price | $0.6828 |
| Largest weekly change | +31.1% (Jun 19, 2024) |
| Weeks tracked | 218 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by Major Pharmaceuticals, is $0.5592 per EA (NDC 00904705699), effective Aug 19, 2026.
How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?
Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 37.2%. It has been tracked across 218 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?
Since Jun 22, 2022, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $0.8911 (Jul 13, 2022), with a median of $0.6646 per EA.
Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ASPIRIN-DIPYRIDAM ER 25-200 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?
ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 00904705699) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.